Skip to main content

MoneyWorks4Me

Zim Laboratories - Quaterly Results

05 Nov 2026 Evaluate
The September 2026 quarter revenue stood at Rs. 1042.23 millions, up 17.91% as compared to Rs. 883.94 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2026 is Rs. -21.42 millions as compared to Net Profit of Rs. 1.16 millions of corresponding quarter ended September 2025The company reported a degrowth in operating Profit to 74.12 millions from 82.15 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 1042.23 883.94 17.91 1972.71 1598.22 23.43 3704.82 3756.36 -1.37
Other Income 22.90 20.44 12.04 32.76 35.20 -6.93 113.90 56.21 102.63
PBIDT 74.12 82.15 -9.77 108.05 140.25 -22.96 409.70 488.90 -16.20
Interest 39.38 31.59 24.66 75.81 64.63 17.30 132.02 113.86 15.95
PBDT 34.74 50.56 -31.29 32.24 75.62 -57.37 277.68 375.04 -25.96
Depreciation 62.65 48.28 29.76 114.36 96.18 18.90 193.67 198.91 -2.63
PBT -27.91 2.28 -1324.12 -82.12 -20.56 299.42 84.01 176.13 -52.30
TAX -6.49 1.12 -679.46 -21.96 -4.79 358.46 24.35 58.68 -58.50
Deferred Tax -6.49 1.12 -679.46 -21.96 -4.79 358.46 -8.40 14.21 -159.11
PAT -21.42 1.16 -1946.55 -60.16 -15.77 281.48 59.66 117.45 -49.20
Equity 536.58 487.36 10.10 536.58 487.36 10.10 535.00 487.26 9.80
PBIDTM(%) 7.11 9.29 -23.48 5.48 8.78 -37.58 11.06 13.02 -15.03
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..